This report was first published by Endpoints News. To see the original version, click here
The telehealth company Hims & Hers said it will no longer sell a compounded version of Novo Nordisk’s Wegovy pill, just days after announcing the new product.
The move comes after Novo, which launched its brand-name weight loss pill just last month, said it would take legal action, and US government health agencies threatened to take “decisive steps” against the company.
您已阅读15%（462字），剩余85%（2715字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。